Upregulation of DLC‑1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer model
Cited by 4
Related Papers
Identification of channel-lining residues in the M2 membrane-spanning segment of the GABA(A) receptor alpha1 subunit.
|The Journal of General Physiology|1996|197
A phase 1a dose-escalation, multicenter trial of anti-claudin 18.2 antibody drug conjugate CMG901 in patients with resistant/refractory solid tumors.
|Journal of Clinical Oncology|2023|32
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
|The Lancet Oncology|2024|32